- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.82 | 1.94 |
NAV | ₹491.25 | ₹415.05 |
Fund Started | 10 May 2004 | 04 Jun 1999 |
Fund Size | ₹8259.60 Cr | ₹3670.62 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.82
1.94
NAV
₹491.25
₹415.05
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8259.60 Cr
₹3670.62 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 14.35% | 20.05% |
3 Year | 22.38% | 27.07% |
5 Year | 22.41% | 24.82% |
1 Year
14.35%
20.05%
3 Year
22.38%
27.07%
5 Year
22.41%
24.82%
Holding Analysis
Equity | 99.71% | 97.41% |
Cash | 0.29% | 2.51% |
Equity
99.71%
97.41%
Cash
0.29%
2.51%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.88% |
Divi's Laboratories Ltd. | 9.57% |
Lupin Ltd. | 6.30% |
Cipla Ltd. | 6.01% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Dr. Reddy's Laboratories Ltd. | 5.25% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.63% |
Medplus Health Services Ltd. | 3.54% |
Vijaya Diagnostic Centre Ltd. | 3.43% |
Abbott India Ltd. | 3.23% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.98% |
Divi's Laboratories Ltd. | 6.63% |
Max Healthcare Institute Ltd. | 6.28% |
Cipla Ltd. | 5.07% |
Lonza Group Ag | 4.97% |
Lupin Ltd. | 4.80% |
Poly Medicure Ltd. | 3.79% |
Mankind Pharma Ltd. | 3.76% |
Krishna Institute of Medical Sciences Ltd | 3.64% |
Jupiter Life Line Hospitals Ltd. | 3.20% |
Fund Manager
Name | Akshay Sharma | Tanmaya Desai |
Start Date | 01 Dec 2022 | 27 Jun 2011 |
Name
Akshay Sharma
Tanmaya Desai
Start Date
01 Dec 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 May 2004 | 04 Jun 1999 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999